… main clinical features of COVID-19 and potential role of microbiota in COVID-19. SARS-CoV …
COVID-19 share similar clinical features, although the estimated fatality rate of COVID-19 is …

… anti-coronavirus activities. We also discuss the lessons learned from COVID-19 and other
infectious diseases with regard to drug repurposing strategies, pan-coronavirus drug targets, …

… This study aimed to assess the diagnostic, prognostic, and therapeutic value of ddPCR in
COVID-19 patients, regardless of the sample type. It also aimed to compare the diagnostic …

… as a novel therapeutic strategy to attenuate the vital organ injuries in COVID-19 (Fig. 1),
whilst simultaneously providing beneficial sedative effects to enable oxygen therapy via either …

… vitamin D values, risk of COVID-19 infection was higher compared to those with replete values
(OR = … Reduced vitamin D values resulted in a higher infection risk, mortality and severity …

… values of 0.31 (according to the used anti-COVID-19 assay, CoViTris2020 is the most potent
SARS-CoV-2 inhibitor discovered till now) and 1.01 μM, and amazingly presented about 65-…

… Having a comprehensive knowledge of the diagnostic approaches of SARS-CoV-2, and
its pathogenesis will be of great value in designing a long-term strategy to tackle COVID-19. …

… , we discuss the therapeutic advances in the treatment of COVID-19 since the … therapy (KRT),
as well as kidney transplant recipients, who are all at increased risk of adverse COVID-19 …

… Montelukast sodium and maribavir, proposed as potential candidate treatments for patients
with COVID-19, 102 showed IC 50 values of 7.3 and 20 μM against SARS-CoV-2 M pro , …

… 2 | Trials of COVID-19 drug candidates that may be … We chose threshold values of enrolment
in consideration of … that approximately 5% of the total COVID-19 trial arms in our assessment …